Houlihan Lokey Advises Infinity Laboratories
Houlihan Lokey is pleased to announce that Infinity Laboratories (Infinity), a portfolio company of Imperial Capital (Imperial), has been acquired by Eurofins Scientific (Eurofins). The transaction closed on September 13, 2024.
The acquisition further bolsters Eurofins' biopharmaceutical and medical device network’s national and global footprint to provide the most comprehensive and competitive service offering in the industry. In return, Infinity and its clients gain access to Eurofins’ extensive laboratory network, analytical portfolio, and leading IT systems.
Infinity was founded in 1991 as a regional microbiology laboratory committed to quality solutions and customer success. Today, Infinity has expanded into eight facilities across the U.S. to proudly serve its pharmaceutical, biotechnology, and medical device partners with the combined flexibility and customer engagement of a local partner and the best-in-class systems of a coast-to-coast network.
Imperial is a Toronto-based private equity firm that invests in middle-market healthcare businesses in the U.S. and Canada. Imperial employs a partnership approach, applying a well-crafted strategy, assembling effective teams, instilling best practices, and committing significant capital and operating resources to drive organic and acquisitive growth.
Eurofins is a global leader in food, environment, pharmaceutical and cosmetic product testing and discovery pharmacology, forensics, advanced material sciences, and agriscience contract research services. It is also one of the market leaders in certain testing and laboratory services for genomics, in the support of clinical studies, and in biopharma contract development and manufacturing. Eurofins also has a rapidly developing presence in highly specialized and molecular clinical diagnostic testing and in vitro diagnostic products.
Houlihan Lokey served as the exclusive financial advisor to Infinity and Imperial and assisted in marketing, structuring, and negotiating the transaction on their behalf. This transaction underscores Houlihan Lokey’s success and preeminent coverage of the testing, inspection, certification, and compliance services sector.